Serina Therapeutics SER
NYSE SER
$2.63 -0.14 (-5.05%)
At close: Aug 20, 2026 · 4:00 PM EDT

Serina Therapeutics (SER) Tax Rate (2019)

Serina Therapeutics (SER) posted Tax Rate of 0.66% for Q4 2019, up 60.55% sequentially from 1.68% in Q3 2019.

Serina Therapeutics (SER) Tax Rate (2019) Analysis & Trends

Serina Therapeutics has reported Tax Rate for 1 years, with the latest figure at 0.66% in Q4 2019.

  • Quarterly Tax Rate changed N/A year-over-year to 0.66% in Q4 2019, while the trailing twelve-month figure through Dec 2019 was 1.21% (changed N/A YoY) and the FY2025 annual result came in at 0.09%, changed N/A from the prior year.
  • Tax Rate improved to 0.66% in Q4 2019 per SER's latest filing, from 1.68% in the prior quarter.
  • Over five years, Tax Rate peaked at 0.1% in Q2 2019 and troughed at 2.33% in Q1 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Tax Rate (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 20.98%
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 15.11%
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn 10.91%
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn -1.96%
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 24.15%
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 7.49%
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn -16.71%
8 Royalty Pharma 26.98 Bn 26.14 Bn - -
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn 34.12%
10 Serina Therapeutics 43.17 Mn 20.15 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2019 -0.66%
Dec 31, 2019 -0.66%
Dec 31, 2019 -0.66%
Sep 30, 2019 -1.68%
Sep 30, 2019 -1.68%
Sep 30, 2019 -1.68%
Jun 30, 2019 -0.10%
Jun 30, 2019 -0.10%
Jun 30, 2019 -0.10%
Mar 31, 2019 -2.33%
Mar 31, 2019 -2.33%
Mar 31, 2019 -2.33%